CL
54
3
MTCH
20
-8
SCHW
62
-2
ED
45
3
EL
15
-3
PBI
56
-2
DOV
65
-4
CSCO
58
-2
BXP
49
-3
EBAY
42
-2
BDX
56
10
EXPD
43
-4
SYF
86
-6
PVH
60
-4
SJM
9
-5
AA
56
15
SE
60
-3
CCI
30
-11
ADP
65
-3
GILD
47
-8
CL
54
3
MTCH
20
-8
SCHW
62
-2
ED
45
3
EL
15
-3
PBI
56
-2
DOV
65
-4
CSCO
58
-2
BXP
49
-3
EBAY
42
-2
BDX
56
10
EXPD
43
-4
SYF
86
-6
PVH
60
-4
SJM
9
-5
AA
56
15
SE
60
-3
CCI
30
-11
ADP
65
-3
GILD
47
-8
Financhill
Back

Sophia Genetics SA Vs. Halozyme Therapeutics Industry Stock Comparison

Buy
62

SOPH
Sophia Genetics SA

Last Price:
3.52
Seasonality Move:
14.6%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Buy
62
Sophia Genetics SA (SOPH) is a Buy

Is Sophia Genetics SA a Buy, Sell or Hold?

  • The current Sophia Genetics SA [SOPH] share price is $3.53. The Score for SOPH is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
  • SOPH is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SOPH Stock Price Chart

What is Sophia Genetics SA's stock price today?

  • The Sophia Genetics SA share price today is $3.53
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SOPH is experiencing selling pressure, which indicates risk of future bearish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

SOPH Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.03 Buy
Relative Strength Index (14 RSI): 48.02 Sell
Chaikin Money Flow: -38205 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.39 - 3.71) Sell
Bollinger Bands (100): (3.41 - 4.37) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

SOPH Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.62 Sell
20-day SMA: 3.56 Sell
50-day SMA: 3.64 Sell
200-day SMA: 4.37 Sell
8-day EMA: 3.64 Sell
20-day EMA: 3.61 Sell
50-day EMA: 3.66 Sell
200-day EMA: 4.07 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Sophia Genetics SA Earnings Growth & SOPH Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.19 per share, and an increase next year of $0.14 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

Sophia Genetics SA Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):